INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsLowNeutral
Announced Mon, 29 Sept · 18:07 IST

Ind-Swift Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025

Board & Shareholder Meetings View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories held its 30th AGM on September 29, 2025 via video conferencing from 11:30 AM to 11:55 AM, with 44 shareholders attending through VC. The Chairman and Managing Director, Sh. N.R. Munjal, chaired the meeting and addressed members on business performance, financials, and outlook. All nine resolutions were passed with the required majority through e-voting, including adoption of audited financial statements for FY ended March 31, 2025, re-appointment of Mr. Rishav Mehta as Director, ratification of cost auditor remuneration, appointment of a secretarial auditor, and appointment of two Independent Directors (Sh. Subodh Gupta and Sh. Prabhat Khurana). Three related party transaction resolutions under Section 188(1)(f) of the Companies Act, 2013 were also approved. Nine shareholders had registered as speakers, but none were present, so no Q&A took place. The detailed voting results and scrutinizer's report will be shared with the exchanges and posted on the company's website in due course.

Likely market impact

This is a routine procedural filing confirming that all agenda items, including financial approvals and board appointments, have shareholder backing. No material surprises were disclosed, so the immediate stock impact is likely neutral; investors should watch for the separate voting results filing for exact vote tallies.